Potency of an HIV-SAM™ vaccine in a heterologous prime-boost vaccination regimen
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-4690
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Potency of an HIV-SAM™ vaccine in a heterologous prime-boost vaccination regimen ; volume:9 ; number:2 ; day:13 ; month:9 ; year:2012 ; pages:1 ; date:9.2012
Retrovirology ; 9, Heft 2 (13.9.2012), 1, 9.2012
- Urheber
-
Banerjee, K.
- Beteiligte Personen und Organisationen
-
Cu, Y.
Sun, Y.
Hartog, K.
Dey, A.
Brito, L.
Verma, A.
Nandi, A.
Sarkar, P.
Valiante, NM
Geall, AJ
Barnett, SW
Otten, GR
SpringerLink (Online service)
- DOI
-
10.1186/1742-4690-9-S2-P312
- URN
-
urn:nbn:de:1111-2016080725323
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:52 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Banerjee, K.
- Cu, Y.
- Sun, Y.
- Hartog, K.
- Dey, A.
- Brito, L.
- Verma, A.
- Nandi, A.
- Sarkar, P.
- Valiante, NM
- Geall, AJ
- Barnett, SW
- Otten, GR
- SpringerLink (Online service)
Ähnliche Objekte (12)
Exploring heterologous prime-boost vaccination approaches to enhance influenza control in pigs
Heterologous prime-boost with A(H5N1) pandemic influenza vaccines induces broader cross-clade antibody responses than homologous prime-boost
Heterologous prime-boost: an important candidate immunization strategy against Tembusu virus
Preferential targeting of conserved Gag regions after vaccination with a heterologous DNA prime Modified Vaccinia Ankara boost HIV vaccine regime
Reactogenicity after heterologous and homologous COVID-19 prime-boost vaccination regimens: descriptive interim results of a comparative observational cohort study
Accelerated heterologous prime-boost adenovirus vector-based SIV vaccine in neonatal rhesus monkeys
Optimization of heterologous DNA-prime, protein boost regimens and site of vaccination to enhance therapeutic immunity against human papillomavirus-associated disease
Prime and Boost Vaccination Elicit a Distinct Innate Myeloid Cell Immune Response
Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization
Heterologous prime-boost-boost immunisation of Chinese cynomolgus macaques using DNA and recombinant poxvirus vectors expressing HIV-1 virus-like particles
Hyperglycosylated gp120 mutants elicit improved CD4-binding site directed antibodies in a heterologous prime:boost regimen
BNT162b2 booster after heterologous prime-boost vaccination induces potent neutralizing antibodies and T cell reactivity against SARS-CoV-2 Omicron BA.1 in young adults
Exploring heterologous prime-boost vaccination approaches to enhance influenza control in pigs
Heterologous prime-boost with A(H5N1) pandemic influenza vaccines induces broader cross-clade antibody responses than homologous prime-boost
Heterologous prime-boost: an important candidate immunization strategy against Tembusu virus
Preferential targeting of conserved Gag regions after vaccination with a heterologous DNA prime Modified Vaccinia Ankara boost HIV vaccine regime
Reactogenicity after heterologous and homologous COVID-19 prime-boost vaccination regimens: descriptive interim results of a comparative observational cohort study
Accelerated heterologous prime-boost adenovirus vector-based SIV vaccine in neonatal rhesus monkeys
Optimization of heterologous DNA-prime, protein boost regimens and site of vaccination to enhance therapeutic immunity against human papillomavirus-associated disease
Prime and Boost Vaccination Elicit a Distinct Innate Myeloid Cell Immune Response
Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization
Heterologous prime-boost-boost immunisation of Chinese cynomolgus macaques using DNA and recombinant poxvirus vectors expressing HIV-1 virus-like particles
Hyperglycosylated gp120 mutants elicit improved CD4-binding site directed antibodies in a heterologous prime:boost regimen
BNT162b2 booster after heterologous prime-boost vaccination induces potent neutralizing antibodies and T cell reactivity against SARS-CoV-2 Omicron BA.1 in young adults
Exploring heterologous prime-boost vaccination approaches to enhance influenza control in pigs
Heterologous prime-boost with A(H5N1) pandemic influenza vaccines induces broader cross-clade antibody responses than homologous prime-boost
Heterologous prime-boost: an important candidate immunization strategy against Tembusu virus
Preferential targeting of conserved Gag regions after vaccination with a heterologous DNA prime Modified Vaccinia Ankara boost HIV vaccine regime
Reactogenicity after heterologous and homologous COVID-19 prime-boost vaccination regimens: descriptive interim results of a comparative observational cohort study
Accelerated heterologous prime-boost adenovirus vector-based SIV vaccine in neonatal rhesus monkeys
Optimization of heterologous DNA-prime, protein boost regimens and site of vaccination to enhance therapeutic immunity against human papillomavirus-associated disease
Prime and Boost Vaccination Elicit a Distinct Innate Myeloid Cell Immune Response
Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization
Heterologous prime-boost-boost immunisation of Chinese cynomolgus macaques using DNA and recombinant poxvirus vectors expressing HIV-1 virus-like particles
Hyperglycosylated gp120 mutants elicit improved CD4-binding site directed antibodies in a heterologous prime:boost regimen